Phase I Trial of FOLFIRI in Combination With Sorafenib and Bevacizumab in Patients With Advanced Gastrointestinal Malignancies.
Journal of Clinical Oncology - United States
doi 10.1200/jco.2014.32.3_suppl.551
Full Text
Open PDFAbstract
Available in full text
Date
January 20, 2014
Authors
Publisher
American Society of Clinical Oncology (ASCO)